AbbVie (ABBV) Financials

$295.03

$0.58 (0.20%)

As on 13-Nov-2026 16:05EST

Market cap

$509,498 Mln

Revenue (TTM)

$66,014 Mln

P/E Ratio

49.5

P/B Ratio

245.3

Div. Yield

2.4 %

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Operating Revenue	66,014.00	61,160.00	56,334.00	54,318.00	58,054.00	56,197.00
Cost of Revenue	15,677.00	18,204.00	16,904.00	20,415.00	17,414.00	17,446.00
Gross Profit	50,337.00	42,956.00	39,430.00	33,903.00	40,640.00	38,751.00
Operating Expenses	26,879.00	22,865.00	30,293.00	21,146.00	22,523.00	20,827.00
Operating Profit (EBIT)	23,458.00	20,091.00	9,137.00	12,757.00	18,117.00	17,924.00
Other Income	--	--	--	--	-2,596.00	-2,551.00
Profit before Tax	12,814.00	6,597.00	3,716.00	6,250.00	13,477.00	12,989.00
Provision for Tax	2,466.00	2,364.00	-570.00	1,377.00	1,632.00	1,440.00
Profit after Tax (Net Income)	10,350.00	4,226.00	4,278.00	4,863.00	11,836.00	11,542.00
Minority Interest	-6.00	-7.00	-8.00	-10.00	-9.00	-7.00
Consolidated Profit	--	--	--	--	11,836.00	11,542.00

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Shareholder's Funds	-5,935.00	-3,228.00	3,364.00	10,397.00	17,287.00	15,436.00
Minority Interest	-6.00	42.00	39.00	37.00	33.00	28.00
Non-Current Liabilities	99,361.00	93,899.00	93,048.00	86,473.00	91,980.00	95,899.00
Current Liabilities	41,642.00	43,289.00	38,749.00	37,841.00	29,538.00	35,194.00
Total Liabilities	176,757.00	133,960.00	135,161.00	134,711.00	138,805.00	146,529.00

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Non-Current Assets	101,446.00	104,898.00	109,579.00	101,709.00	110,342.00	118,601.00
Current Assets	33,669.00	29,062.00	25,582.00	33,002.00	28,463.00	27,928.00
Total Assets	176,776.00	133,960.00	135,161.00	134,711.00	138,805.00	146,529.00
Total Debt*	70,822.00	69,068.00	67,841.00	60,120.00	64,191.00	77,575.00
Net Current Assets	-7,973.00	-14,227.00	-13,167.00	-4,839.00	-1,075.00	-7,266.00

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Cash From Operating Activities	--	19,030.00	18,806.00	22,839.00	24,943.00	22,777.00
Cash Flow from Investing Activities	--	-6,643.00	-20,820.00	-2,009.00	-623.00	-2,344.00
Cash from Financing Activities	--	-12,724.00	-5,211.00	-17,222.00	-24,803.00	-19,039.00
Net Cash Inflow / Outflow	--	--	--	--	-483.00	1,297.00

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Adjusted EPS ($)	5.84	2.38	2.41	2.74	6.66	6.49
Cash EPS ($)	--	6.97	7.14	7.65	11.42	11.28
Adjusted Book Value ($)	--	--	1.90	5.87	9.72	8.68
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	10.73	10.61	12.89	14.03	12.81
Free Cash Flow per Share ($)	--	10.04	10.06	12.45	13.64	12.37

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
ROCE (%)	--	6.17	6.04	6.40	13.57	11.95
ROE (%)	--	6,214.71	62.18	35.13	72.34	80.90
ROA (%)	5.85	3.14	3.17	3.56	8.30	7.77
EBIT Margin (%)	26.50	15.52	11.58	15.60	27.06	27.42
Net Margin (%)	15.68	6.91	7.59	8.95	21.34	21.52
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Revenue Growth (%)	10.68	0.09	0.04	-0.06	0.03	0.23
EBIT Growth (%)	285.20	45.46	-23.01	-46.05	1.91	163.36
Net Profit Growth (%)	334.44	-1.22	-12.03	-58.91	2.55	150.04
EPS Growth (%)	333.38	-0.01	-0.12	-0.59	0.03	1.50
Book Value Growth (%)	-4,203.16	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Price / Earnings	49.53	95.92	73.65	56.47	24.28	20.86
Price / Book Value	245.29	-125.57	93.66	26.41	16.62	15.60
Dividend Yield (%)	2.35	--	--	--	--	--
EV/EBITDA	25.20	26.61	25.31	18.75	14.16	12.89
Close Price ($)	261.59	228.49	177.70	154.97	161.61	135.40
High Price ($)	269.39	244.81	207.32	168.11	175.91	136.83
Low Price ($)	191.00	164.39	153.58	130.96	128.26	101.81
Market Cap ($ Cr)	509,497.70	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Debt to Equity	-10.53	-21.40	20.17	5.78	3.71	5.03
Short term debt to equity ratio	-1.41	-2.71	2.02	0.69	0.25	0.82
Current Ratio	0.81	0.67	0.66	0.87	0.96	0.79
Quick Ratio	0.69	0.56	0.55	0.76	0.84	0.70
Interest Coverage	5.45	3.28	2.32	3.81	7.04	6.36

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Debtors to sales (%)	20.94	20.58	19.38	20.54	19.39	17.75
Asset Turnover	0.37	0.45	0.42	0.40	0.41	0.38
Receivable days	--	70.20	71.56	75.34	66.79	61.09
Inventory Days	--	91.61	89.45	68.68	70.34	67.39
Payable days	--	65.58	71.66	59.24	60.99	53.99
Cash Conversion Cycle	--	96.23	89.35	84.79	76.13	74.49

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Income Statement ($ Mln)